TropT sensitive rapid assay

• Highly specific and sensitive
  Troponin T is the most appropriate cardiac marker for myocardial infarction. The TROP T Sensitive rapid assay is designed for qualitative determination of troponin T in the blood as an aid for risk stratification of patients with unstable angina pectoris and for diagnosis of myocardial infarction, means ST-segment elevation myocardial infarction (STEMI) and Non-ST-segment elevation myocardial infarction (NSTEMI) among patients suffering from thoracic pain or who are suspected of experiencing myocardial infarction or acute coronary syndrome in accordance with the redefinition of myocardial infarction by the ESC (European Society of Cardiology) and the ACC (American College of Cardiology)¹ as well as the guidelines by the ACC and the AHA (American Heart Association)²
• Saves valuable time
  The assay is easy to use and easy to read. It gives a reliable "yes/no" result within 15-max 20 minutes after application of anticoagulated whole venous blood (heparin or EDTA) thus allowing rapid detection of myocardial damage.
• Large diagnostic time window
  With the TROPT Sensitive rapid assay you can diagnose myocardial damage up to 14 days after it has occurred.

• Test principle
  TROPT Sensitive rapid assay detects Troponin T by an immunoassay with two cardiac-specific monoclonal antibodies. Troponin T forms a sandwich complex with the two antibodies that becomes visible in the detection field as a red line (qualitative "yes/no" result) due to the gold label of one of the two antibodies.
• Positive and negative results
  A positive result ( > 0.1 ng/mL) is evidence of cell damage in the myocardium.
• A negative result does not rule out a cardiac infarction or myocardial cell damage with certainty. If suspicion of an infarction persists, the test should be repeated at suitable time intervals in accordance with the guidelines from the professional cardiology societies³. A negative troponin T result must not be used as the sole diagnostic criterion.